Codi QR

Serum and Cerebrospinal Fluid Pharmacokinetics of Intravenous and Oral Lamivudine in Human Immunodeficiency Virus-Infected Children

We studied the pharmacokinetics of intravenously and orally administered lamivudine at six dose levels ranging from 0.5 to 10 mg/kg of body weight in 52 children with human immunodeficiency virus infection. A two-compartment model with first-order elimination from the central compartment was simulta...

Descripció completa

Guardat en:
Publicat a:Antimicrob Agents Chemother
Autors principals: Mueller, Brigitta U., Lewis, Linda L., Yuen, Geoffrey J., Farley, Maureen, Keller, Amy, Church, Joseph A., Goldsmith, Jonathan C., Venzon, David J., Rubin, Marc, Pizzo, Philip A., Balis, Frank M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 1998
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC106021/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9835513/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.12.3187
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars